We also reported that ASOs targeting either Notch3 or Notch3 mutants replicating the pathogenic variant of LMS, inhibit Notch3 mRNA and improve the cortical osteopenia found in Notch3em1Ecan mice [23, 24]. The gene discussed is NOTCH3; the disease is Osteopenia.